MGMT prognostic impact on glioblastoma is dependent on therapeutic modalities (Q48312103)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 12 January 2007

Language	Label	Description	Also known as
English	MGMT prognostic impact on glioblastoma is dependent on therapeutic modalities	scientific article published on 12 January 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17219056

MGMT prognostic impact on glioblastoma is dependent on therapeutic modalities (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17219056

1 reference

based on heuristic

inferred from title

Alexandra Benouaich-Amiel

6

object named as

Alexandra Benouaich-Amiel

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

5

object named as

Nathalie Auger

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17219056

author name string

Emmanuelle Crinière

1

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17219056

Gentian Kaloshi

2

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17219056

Florence Laigle-Donadey

3

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17219056

Julie Lejeune

4

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17219056

Sibille Everhard

7

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17219056

Karima Mokhtari

8

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17219056

Marc Polivka

9

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17219056

Jean-Yves Delattre

10

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17219056

Khê Hoang-Xuan

11

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17219056

Joëlle Thillet

12

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17219056

Marc Sanson

13

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17219056

publication date

12 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17219056

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17219056

83

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17219056

2

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17219056

173-179

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17219056

Glioblastomas with an oligodendroglial component: a pathological and molecular study

1 reference

https://api.crossref.org/works/10.1007%2FS11060-006-9320-0

21 January 2018

O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Killing and mutagenic actions of dacarbazine, a chemotherapeutic alkylating agent, on human and mouse cells: effects of Mgmt and Mlh1 mutations

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p53 is involved in regulation of the DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) by DNA damaging agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective study of cognitive functions following conventional radiotherapy for supratentorial gliomas in young adults: 4-year results.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inverse correlation between the expression of O6-methylguanine-DNA methyl transferase (MGMT) and p53 in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Roles of MGMT and MLH1 proteins in alkylation-induced apoptosis and mutagenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Promoter Hypermethylation of the DNA Repair Gene O6‐Methylguanine‐DNA Methyltransferase is an Independent Predictor of Shortened Progression Free Survival in Patients with Low‐grade Diffuse Astrocytomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Loss of expression of DNA repair enzymes MGMT, hMLH1, and hMSH2 during tumor progression in gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of sequential versus concurrent chemotherapy and radiotherapy on survival and toxicity in patients with newly diagnosed high-grade astrocytoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predicting lung cancer by detecting aberrant promoter methylation in sputum

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

O(6)-methylguanine-DNA methyltransferase gene (MGMT) expression in human glioblastomas in relation to patient characteristics and p53 accumulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detecting homozygous deletions in the CDKN2A(p16(INK4a))/ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCR.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

O6-methylguanine-DNA methyltransferase methylation and TP53 mutation in malignant astrocytomas and their relationships with clinical course

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic impact of molecular markers in a series of 220 primary glioblastomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olig2 expression, GFAP, p53 and 1p loss analysis contribute to glioma subclassification

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of the alkyltransferase (MGMT) gene by DNA damaging agents and the glucocorticoid dexamethasone and comparison with the response of base excision repair genes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

O6-methylguanine-DNA methyltransferase-deficient phenotype in human gliomas: frequency and time to tumor progression after alkylating agent-based chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of clinical features and methylation status of MGMT gene promoter in glioblastomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11060-006-9320-0

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17219056

release_2lcj4rt74vaenm6sqi3eimjjja

1 reference

https://api.fatcat.wiki/v0/release/2lcj4rt74vaenm6sqi3eimjjja

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17219056

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48312103&oldid=2209316373"